PDF
ePub
Citation
Print
Abstract
Purpose
To evaluate the efficacy and safety of immediate sequential bilateral cataract surgery with respect to patient outcomes and complication rates.
Methods
From January 2010 to December 2014, we conducted a retrospective study of patients who had immediate sequential bilateral cataract surgery (ISBCS) and delayed sequential bilateral cataract surgery (DSBCS) with an interval of one to two months between the first and the fellow eye operations. The changes in visual acuity, manifest spherical equivalent, and re-fractive error of 140 eyes of 70 patients of both groups were compared postoperatively at one month. The incidence of endoph-thalmitis was investigated during the same period.
Results
At one month postoperatively, log MAR best corrected visual acuity were measured to be 0.06 ± 0.72 in the ISBCS group and 0.09 ± 0.66 in the DSBCS group, and that of the fellow eyes were 0.07 ± 0.64 and 0.07 ± 0.18, respectively ( p = 0.331, p = 0.781, respectively). The postoperative spherical equivalents were -0.18 ± 0.23 D in the ISBCS group and -0.19 ± 0.25 D in the DSCBS group, and that of the fellow eyes were -0.15 ± 0.18 D and -0.16 ± 0.21 D, respectively. There were no significant statistical differences between the two groups ( p = 0.835, p = 0.676, respectively). The postoperative refractive error was -0.20 ± 0.21 D in the ISCBS group and -0.18 ± 0.13 D in the DSBCS group, and that of the fellow eyes were -0.14 ± 0.22 D and -0.19 ± 0.22 D, respectively ( p = 0.482, p = 0.237, respectively). A total of 21,140 eyes had cataract surgery performed, and only 10 eyes (0.05%) developed endophthalmitis. Endophthalmitis did not occur in the ISBCS group.
References
1. Chung JK, Park SH, Lee WJ, Lee SJ. Bilateral cataract surgery: a controlled clinical trial. Jpn J Ophthalmol. 2009; 53:107–13.
2. Talbot EM, Perkins A. The benefit of second eye surgery. Eye (Lond). 1998; 12:(Pt 6). 983–9.
3. Lundström M, Brege KG, Florén I. . Impaired visual function after cataract surgery assessed using the Catquest questionnaire. J Cataract Refract Surg. 2000; 26:101–8.
4. Nassiri N, Nassiri N, Sadeghi Yarandi SH, Rahnavardi M. Immediate vs delayed sequential cataract surgery: a comparative study. Eye (Lond). 2009; 23:89–95.
5. Arshinoff SA, Bastianelli PA. Incidence of postoperative endoph-thalmitis after immediate sequential bilateral cataract surgery. J Cataract Refract Surg. 2011; 37:2105–14.
6. Serrano-Aguilar P, Ramallo-Fariña Y, Cabrera-Hernández JM. . Immediately sequential versus delayed sequential bilateral cata-ract surgery: safety and effectiveness. J Cataract Refract Surg. 2012; 38:1734–42.
7. Sarikkola AU, Uusitalo RJ, Hellstedt T. . Simultaneous bilateral versus sequential bilateral cataract surgery: Helsinki Simultaneous Bilateral Cataract Surgery Study Report 1. J Cataract Refract Surg. 2011; 37:992–1002.
8. Lundström M, Albrecht S, Nilsson M, Aström B. Benefit to pa-tients of bilateral same-day cataract extraction: randomized clin-ical study. J Cataract Refract Surg. 2006; 32:826–30.
9. Lansingh VC, Eckert KA, Strauss G. Benefits and risks of immedi-ately sequential bilateral cataract surgery: a literature review. Clin Experiment Ophthalmol. 2015; 43:666–72.
10. Arshinoff SA. Same-day cataract surgery should be the standard of care for patients with bilateral visually significant cataract. Surv Ophthalmol. 2012; 57:574–9.
11. Handerson BA, Schneider J. Same-day cataract surgery should not be the standard of care for patients with bilateral visually sig-nificant cataract. Surv Ophthalmol. 2012; 57:580–3.
12. Serrano-Aguilar P, Ramallo-Fariña Y, Cabrera-Hernández JM. Immediately sequential versus delayed sequential bilateral cataract surgery: safety and effectiveness. J Cataract Refract Surg. 2012; 38:1734–42.
13. Rosen ES. Immediate sequential bilateral cataract surgery. J Cataract Refract Surg. 2012; 38:1707–8.
14. Grzybowski A, Krzyż anowska-Berkowska P. Immediate sequen-tial bilateral cataract surgery: who might benefit from the proce-dure? J Cataract Refract Surg. 2013; 39:1119–20.
15. Smith GT, Liu CS. Is it time for a new attitude to “simultaneous” bilateral cataract surgery? Br J Ophthalmol. 2001; 85:1489–96.
16. Leivo T, Sarikkola AU, Uusitalo RJ. . Simultaneous bilateral cataract surgery: economic analysis; Helsinki Simultaneous Bilateral Cataract Surgery Study Report 2. J Cataract Refract Surg. 2011; 37:1003–8.
17. Neel ST. A cost-minimization analysis comparing immediate se-quential cataract surgery and delayed sequential cataract surgery from the payer, patient, and societal perspectives in the United States. JAMA Ophthalmol. 2014; 132:1282–8.
18. Buzard K, Liapis S. Prevention of endophthalmitis. J Cataract Refract Surg. 2004; 30:1953–9.
19. Wood M, Bowman R, Daya SM. Prophylactic cefuroxime and en-dophthalmitis in Tanzania, East Africa. J Cataract Refract Surg. 2008; 34:9–10.
20. Francis IC, Roufas A, Figueira EC. . Endophthalmitis follow-ing cataract surgery: the sucking corneal wound. J Cataract Refract Surg. 2009; 35:1643–5.
21. Barreau G, Mounier M, Marin B. . Intracameral cefuroxime in-jection at the end of cataract surgery to reduce the incidence of en-dophthalmitis: French study. J Cataract Refract Surg. 2012; 38:1370–5.
22. Endophthalmitis Study Group. European Society of Cataract & Refractive Surgeons Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007; 33:978–88.
23. Lin M, Zhang W, Liu Y. . Nosocomial acute-onset post-operative endophthalmitis at a university teaching hospital in China. J Hosp Infect. 2011; 79:323–7.
24. Galvis V, Tello A, Sánchez MA, Camacho PA. Cohort study of in-tracameral moxifloxacin in postoperative endophthalmitis pro- phylaxis. Ophthalmol Eye Dis. 2014; 6:1–4.
25. Ozlem TY, Necati DM, Fatma YM. . Are cefuroxime and van-comycin really safe on the corneal endothelial cells? Graefes Arch Clin Exp Ophthalmol. 2010; 248:415–20.
26. Delyfer MN, Rougier MB, Leoni S. . Ocular toxicity after in-tracameral injection of very high doses of cefuroxime during cata-ract surgery. J Cataract Refract Surg. 2011; 37:271–8.
27. Lane SS, Osher RH, Masket S, Belani S. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. J Cataract Refract Surg. 2008; 34:1451–9.
28. Ekinci Koktekir B, Aslan BS. Safety of prophylactic intracameral moxifloxacin use in cataract surgery. J Ocul Pharmacol Ther. 2012; 28:278–82.
Figure 1.
The aspheric hydrophilic acrylic refractive intra-ocular lens (Clare®, Cristalens, Eragny, France).
Table 1.
Preoperative patient demographics and characteristics
Values are presented as mean ± SD unless otherwise indicated. ISBCS = immediate sequential bilateral cataract surgery; DSBCS = delayed sequential bilateral cataract surgery; CDVA = corrected distance visual acuity; D = diopter; SE = manifest spherical equivalent; IOL = intraocular lens.* Independent t-test.
Table 2.
Clinical outcomes at postoperative 1 month
Values are presented as mean ± SD unless otherwise indicated. ISBCS = immediate sequential bilateral cataract surgery; DSBCS = delayed sequential bilateral cataract surgery; CDVA = corrected distance visual acuity; SE = manifest spherical equivalent; D = diopter; RE = refractive error.* Independent t-test; † Fellow eye; ‡ Refractive error (postoperative spherical equivalent- intraocular lens target diopter).
Table 3.
Incidence of endophthalmitis after cataract surgery at HanGil Eye Hospital
XML Download